KC-4223
RAMP3 (receptor activity modifying protein 3) encodes a single-transmembrane protein that modulates the ligand specificity and trafficking of G protein-coupled receptors. It partners with calcitonin receptor-like receptor to form adrenomedullin and CGRP receptors, and with calcitonin receptor to form amylin receptors. RAMP3 is widely expressed in cardiovascular, renal, and metabolic tissues and plays important roles in blood pressure regulation, angiogenesis, and metabolic homeostasis.
CALCR (calcitonin receptor; important alias: CTR) encodes the G protein-coupled receptor for calcitonin, a peptide hormone that regulates calcium homeostasis and bone metabolism. When heterodimerized with RAMP3, it forms the amylin receptor, which mediates the effects of amylin on glucose metabolism and appetite regulation. The calcitonin/amylin receptor system is a key target for the treatment of osteoporosis, obesity, and diabetes mellitus.
| Catalog Number | KC-4223 |
|---|---|
| Cell Line Name | 293T-CRE-Luc2-RAMP3-CALCR Cell Line |
| NCBI/UniProt Accession Number | NM_005856.2, NM_001164738.2 |
| Clone Number | 26-19# |
| Host Cell Line | 293T-CRE-Luc2 |
| Description | HEK293T CRE-Luc2 reporter cell line engineered to co-express human RAMP3 and calcitonin receptor (CALCR), enabling cAMP pathway activation studies for amylin and calcitonin receptor drug screening |
| Quantity | One vial of frozen cells (≥2×106 cells) |
| Stability | Stable in culture over a minimum of 10 passages |
| Application | Drug screening and biological assays |
| Freezing Medium | 70% DMEM+20% FBS+10% DMSO |
| Propagation Medium | DMEM+10%FBS+1μg/mL Puromycin+150μg/mL Hygromycin |
| Selection Marker | Puromycin, Hygromycin |
| Morphology | Epithelial-like |
| Subculture | Split at a ratio of 1:5–1:8 every 2–3 days |
| Incubation | 37°C with 5% CO₂ |
| Storage | Liquid nitrogen immediately upon receiving |
| Doubling Time | Estimated 16–31 hours |
| Mycoplasma Status | Negative |
| In Vivo Validation | NA |
Hay DL, et al. RAMPs: their role in GPCR signaling and pharmacology. Pharmacol Rev. 2016;68(2):505-533.
Poyner DR, et al. Pharmacology of calcitonin and amylin receptors. Pharmacol Rev. 2002;54(2):233-255.
Braymer J, et al. The amylin receptor: structure, signaling, and therapeutic potential. Trends Endocrinol Metab. 2021;32(10):704-718.